CUAMC
China Universal Asset Management Company’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Buy |
14,022
+307
| +2% | +$2.94K | 0.01% | 340 |
|
|
2025
Q1 | $86K | Sell |
13,715
-784
| -5% | -$4.92K | 0.01% | 370 |
|
|
2024
Q4 | $118K | Buy |
14,499
+1,365
| +10% | +$11.1K | 0.01% | 375 |
|
|
2024
Q3 | $237K | Buy |
13,134
+6,257
| +91% | +$113K | 0.03% | 286 |
|
|
2024
Q2 | $70.8K | Sell |
6,877
-4,112
| -37% | -$42.4K | 0.01% | 328 |
|
|
2024
Q1 | $117K | Buy |
10,989
+4,363
| +66% | +$46.3K | 0.01% | 356 |
|
|
2023
Q4 | $60.5K | Buy |
6,626
+5,171
| +355% | +$47.2K | 0.01% | 349 |
|
|
2023
Q3 | $15.1K | Buy |
1,455
+738
| +103% | +$7.65K | ﹤0.01% | 315 |
|
|
2023
Q2 | $10.3K | Buy |
717
+153
| +27% | +$2.19K | ﹤0.01% | 316 |
|
|
2023
Q1 | $4.03K | Buy |
564
+141
| +33% | +$1.01K | ﹤0.01% | 389 |
|
|
2022
Q4 | $4.75K | Buy |
423
+56
| +15% | +$628 | ﹤0.01% | 304 |
|
|
2022
Q3 | $4K | Buy |
+367
| New | +$4K | ﹤0.01% | 307 |
|